In vitro embryotoxicity testing of nanomaterals by improvement of embryonic stem cell test

Nano Biomedicine

Volumn 1, Issue 2, 2009, Pages 176-185

  Imai, Koichi ^a  

^a OSAKA DENTAL UNIVERSITY   (Japan)

Author keywords

3D; Embryonic stem cell test; Embryotoxicity; ES cells

Indexed keywords

3D; ALTERNATIVE METHODS; ANIMAL EXPERIMENTS; CHEMICAL SUBSTANCE; CONVENTIONAL METHODS; CULTURE MEDIUM; EMBRYO CULTURE; EMBRYONIC STEM CELLS; EMBRYOTOXICITY; EMBRYOTOXICITY TEST; ES CELLS; FORMAL VALIDATION; HUMAN BODIES; IN-VITRO; IN-VIVO; LABORATORY ANIMALS; MICROMASS; NANOMATERALS; NANOMATERIAL; RESEARCH REPORTS; VALIDATION STUDY;

ANIMALS; NANOSTRUCTURED MATERIALS; RISK PERCEPTION; SAFETY TESTING; STEM CELLS;

CELL CULTURE;

EID: 80051902991     PISSN: 18835198     EISSN: 21854734     Source Type: Journal    
DOI: None     Document Type: Review

References (75)

1. Warheit DB, Sayes CM, Reed KL, Swain KA. Health effects related to nanoparticle expo-sures: environmental, health and safety con-siderations for assessing hazards and risks. Pharmacol Ther 2008; 120: 35-42.
2. Drobne D. Nanotoxicology for safe and sus-tainable nanotechnology. Arh Hig Rada Tok-sikol 2007; 58: 471-478.
3. Genaidy A, Sequeira R, Rinder M, A-Rehim A. Risk analysis and protection measures in acarbon nanofiber manufacturing enterprise: an exploratory investigation. Sci Total Environ. 2009; 407: 5825-5838.
4. Dohner VA, Beegle RG, Miller WT. Asbestos exposure and multiple primary tumors. Am Rev Respir Dis 1975;112:181-199.
5. Rom WN, Lockey JE. Diffuse malignant mesothelioma: a review. West J Med. 1982;137:548-554. (Pubitemid 13194235)
6. Speizer FE. Assessment of the epidemiological data relating lung cancer to air pollution. En-viron Health Perspect 1983;47:33-42. (Pubitemid 13134650)
7. Heppleston AG. Pulmonary toxicology of sil-ica, coal and asbestos. Environ Health Per-spect. 1984;55:111-127. (Pubitemid 14094802)
8. Davis JM, McDonald JC. Low level exposure to asbestos: is there a cancer risk?. Br J Ind Med 1988;45:505-508.
9. Gaensler EA. Asbestos exposure in buildings. Clin Chest Med. 1992;13:231-242.
10. Sturm W, Menze B, Krause J, Thriene B. Use of asbestos, health risks and induced occupa- tional diseases in the former East Germany. Toxicol Lett 1994;72:317-324. (Pubitemid 24180246)
11. Muller J, Delos M, Panin N, Rabolli V, Huaux F, Lison D. Absence of carcinogenic response to multiwall carbon nanotubes in a 2-year bio-assay in the peritoneal cavity of the rat. Toxi-col Sci 2009; 110: 442-448.
12. Morgan K. Development of a preliminary framework for informing the risk analysis and risk management of nanoparticles. Risk Anal. 2005; 25: 1621-1635. (Pubitemid 43188428)
13. Lanone S, Boczkowski J. Biomedical applica- tions and potential health risks of nanomateri- als: molecular mechanisms. Curr Mol Med. 2006;6:651-663. (Pubitemid 44377764)
14. Balbus JM, Maynard AD, Colvin VL, Cas-tranova V, Daston GP, Denison RA, Dreher KL, Goering PL, Goldberg AM, Kulinowski KM, Monteiro-Riviere NA, Oberdorster G, Omenn GS, Pinkerton KE, Ramos KS, Rest KM, Sass JB, Silbergeld EK, Wong BA. Meeting report: hazard assessment for nanoparticles -report from an interdisciplinary workshop. Environ Health Perspect 2007;115: 1654-1659.
15. Bystrzejewska-Piotrowska G, Golimowski J, Urban PL.Nanoparticles: their potential toxic-ity, waste and environmental management. Waste Manag 2009;29:2587-2595.
16. Tanimura T ed, Dokusei Shiken Koza ll, Developmental toxicology, Chijinshokan Co. Ltd, Tokyo, 1992, pp.390-412.
17. Holsapple MP, Farland WH, Landry TD, Monteiro-Riviere NA, Carter JM, Walker NJ, Thomas KV. Research strategies for safety evaluation of nanomaterials, part II: Toxicological and safety evaluation of nanomaterials, current challenges and data needs. Toxicol Sci. 2005;88:12-17. (Pubitemid 41548742)
18. Borm P, Klaessig FC, Landry TD, Moudgil B, Pauluhn J, Thomas K, Trottier R, Wood S. Research strategies for safety evaluation of nanomaterials, part V: role of dissolution in biological fate andeffects of nanoscale particles. Toxicol Sci. 2006;90:23-32.
19. Kumar PV, Asthana A, Dutta T, Jain NK. Intracellular macrophage uptake of rifampicin loaded mannosylated dendrimers. J Drug Target. 2006;14(8):546-556. (Pubitemid 44592888)
20. Shimada A, Kawamura N, Okajima M, Kaewamatawong T, Inoue H, Morita T. Translocation pathway of the intratracheally instilled ultrafine particles from the lung into the blood circulation in the mouse. Toxicol Pathol. 2006;34:949-957. (Pubitemid 46011147)
21. Cheng J, Flahaut E, Cheng SH. Effect of carbon nanotubes on developing zebrafish (Danio rerio) embryos. Environ Toxicol Chem. 2007;26:708-716. (Pubitemid 46663271)
22. Voltan R, Castaldello A, Brocca-Cofano E, Altavilla G, Caputo A, Laus M, Sparnacci K, Ensoli B, Spaccasassi S, Ballestri M, Tondelli L. Preparation and characterization of innovative protein-coated poly(methylmethacrylate) core-shell nanoparticles for vaccine purposes. Pharm Res. 2007;24:1870-1882. (Pubitemid 47389242)
23. Warheit DB, Hoke RA, Finlay C, Donner EM, Reed KL, Sayes CM. Development of a base set of toxicity tests using ultrafine TiO2 particles as a component of nanoparticle risk management. Toxicol Lett. 2007;171:99-110. (Pubitemid 47058824)
24. Baun A, Hartmann NB, Grieger K, Kusk KO. Ecotoxicity of engineered nanoparticles to aquatic invertebrates: a brief review and recommendations for future toxicity testing. Ecotoxicology. 2008;17:387-395.
25. Choi EW, Koo HC, Shin IS, Chae YJ, Lee JH, Han SM, Lee SJ, Bhang DH, Park YH, Lee CW, Youn HY. Preventive and therapeutic effects of gene therapy using silica nanoparticles- binding of GM-CSF gene on white blood cell production in dogs with leukopenia. Exp Hematol. 2008;36:1091-1097.
26. Ramesh R. Nanoparticle-mediated gene delivery to the lung. Methods Mol Biol. 2008;433:301-331.
27. Juzenas P, Chen W, Sun YP, Coelho MA, Generalov R, Generalova N, Christensen IL. Quantum dots and nanoparticles for photodynamic and radiation therapies of cancer. Adv Drug Deliv Rev. 2008;60:1600-1614.
28. Yezhelyev M, Yacoub R, O'Regan R. Inorganic nanoparticles for predictive oncology of breast cancer. Nanomed. 2009;4:83-103.
29. Cheng J, Chan CM, Veca LM, Poon WL, Chan PK, Qu L, Sun YP, Cheng SH. Acute and long-term effects after single loading of functionalized multi-walled carbon nanotubes into zebrafish (Danio rerio). Toxicol Appl Pharmacol. 2009;235:216-225.
30. King-Heiden TC, Wiecinski PN, Mangham AN, Metz KM, Nesbit D, Pedersen JA, Hamers RJ, Heideman W, Peterson RE. Quantum dot nanotoxicity assessment using the zebrafish embryo. Environ Sci Technol. 2009;43:1605-1611.
31. Saito N, Usui Y, Aoki K, Narita N, Shimizu M, Hara K, Ogiwara N, Nakamura K, Ishigaki N, Kato H, Taruta S, Endo M. Carbon nanotubes: biomaterial applications. Chem Soc Rev. 2009;38:1897-1903.
32. Huang S, Chen JC, Hsu CW, Chang WH. Effects of nano calcium carbonate and nano calcium citrate on toxicity in ICR mice and on bone mineral density in an ovariectomized mice model. Nanotechnology. 2009;20:375102.
33. Onuma K, Sato Y, Ogawara S, Shirasawa N, Kobayashi M, Yoshitake J, Yoshimura T, Iigo M, Fujii J, Okada F. Nano-scaled particles of titanium dioxide convert benign mouse fibrosarcoma cells into aggressive tumor cells. Am J Pathol. 2009;175:2171-2183.
34. Spielmann H, Pohl I, Doering B, Moldenhauer F. In vitro embryotoxicity assay using two permanent cell lines: mouse embryonic stem cells and 3T3 fibroblasts. Abstracts of the 23. ETS conference 1995, Dublin; Teratology 1995;51:31A-32A.
35. Spielmann H, Pohl I, Doering B, Liebsch M, Moldenhauer F. The embryonic stem cell test (EST), an in vitro embryotoxicity test using two permanent mouse cell lines: 3T3 fibroblasts and embryonic stem cells. In vitro Toxicol 1997;10:119-127.
36. Scholz G, Genschow E, Pohl I, Bremer S, Paparella M, Raabe H, Moldenhauer F, Southee J, Spielmann H. Prevalidation of the Embryonic Stem Cell Test (EST), a new in vitro embryotoxicity test. Toxicology in Vitro 1999;13:675-681. (Pubitemid 29354195)
37. Spielmann H, Genschow E, Brown NA, Piersma AH, Verhoef A, Spanjersberg MQ, Huuskonen H, Paillard F, Seiler A. Validation of the rat limb bud micromass test in the international ECVAM validation study on three in vitro embryotoxicity tests. Altern Lab Anim 2004;32:245-274. (Pubitemid 39517738)
38. Spielmann H, Seiler A, Bremer S, Hareng L, Hartung T, Ahr H, Faustman E, Haas U, Moffat GJ, Nau H, Vanparys P, Piersma A, Sintes JR, Stuart J. The practical application of three validated in vitro embryotoxicity tests. The report and recommendations of an ECVAM/ZEBET workshop (ECVAM workshop 57). Altern Lab Anim 2006;34:527-538. (Pubitemid 44831681)
39. Imai K, Spielmann H, Nakamura M. An attempt to embryotoxicity test of dental biomaterials using embryonic stem cells. Koku Soshiki Baiyo Kenkyu Kaishi (Jpn J Tissue Culture Soc Dent Res) 1998;7:53-54.
40. Imai K, Spielmann H, Scholz G, Pohl I, Nakamura M. In vitro embryotoxicity tests of dental biomaterials with cardiogenesis differentiation of embryonic stem cells. Proceedings of the 12th Annual Meeting of Japanese Society for Alternatives to Animal Experiments (Alternatives Reserch) 1998:69-70.
41. Imai K, Spielmann H, Scholz G, Pohl I, Nakamura M. In vitro embryotoxicity testing of embryonic stem cells into contracting cardiac myocytes. AATEX 2000;6:153-154.
42. Imai K, Spielmann H, Scholz G, Pohl I, Nakamura M. In vitro embryotoxicity testing of polymeric substances for dental use by differentation of embryonic stem cells. AATEX 2001;8:31-39.
43. Imai K, Kakehi S, Nakamura M. Evaluation of a differentiation screening method using ES-D3 cells with six cytocines, three vitamines, BMP, EmdogainR and four adrenocortical hormones. J Jpn Assoc Regenerative Dent 2004;2:166-181.
44. Imai K, Nakamura M. Use of an alternative for whole animal experiments: determining embryotoxicity of dental biomaterials by differentiation of ES cells, Nippon Yakurigaku Zasshi 2005;125:335-342. (Pubitemid 40874591)
45. Imai K, Nakamura M. In vitro embryotoxicity testing of metals for dental use by differentiation of embryonic stem cell test. Congenital Anomalies 2006;46:34-38. (Pubitemid 44044848)
46. Imai K, Hayakawa T, Nakamura M. Evaluation of in vitro embryotoxicity of dental monomers by differentiation of embryonic stem cells into contracting cardiac myocytes. AATEX 2007;12:171-178.
47. Imai K, Nakamura M. Effects of experimental alloys containing indium for dental use in vitro embryotoxicity test. AATEX 2007;14 (Special Issue) :655-658.
48. Imai K, Kusakawa S, Tanoue A, Nakamura M. Effects on ES-D3 cell differentiation of three-dimensional cell culture system using with collagen gel derived from chum salmon sources. J Oral Tissue Engin 2007;5:81-86.
49. Imai K, Kusakawa S, Tanoue A, Kuwagata M, Senuma M, Furuya M, Takashima H, In vitro embryotoxicity testing of mercury vapour by differentiation of ES-D3 cells. AATEX 2008;13:118-122.
50. Imai K, Kusakawa S, Tanoue A, Kuwagata M, Senuma M, Furuya M, Takashima H, An attempt to cell recovery factor in cell differentiation culture with the embryonic stem cell test (EST). J Oral Tissue Engin 2009;6:152-158.
51. Imai K, Takeda S, Kusakawa S, Tanoue A, Kuwagata M, Senuma M, Furuya M, Takashima H. An attempt to include the human metabolic factor into the embryotoxicity test by mouse ES-D3 cells. ALTEX 2009;26(Spec. Issue):116.
52. Imai K, Suese K, Kusakawa S, Tanoue A, Kuwagata M, Senuma M. Furuya M, Takashima H. Comparison of the cell differentiation level of mouse iPS cells and ES-D3 cells using the embryonic stem cell test (EST) protocol attempting to develop a new in vitro embryotoxicity test. J Oral Tissue Engin. 2009;7:38-43.
53. Imai K, Takeda S, Suese K, Momota Y, Kishimoto N, Nakatsuka M, Kumabe S, Iwai Y, Kusakawa S, Tanoue A. In Vitro embryotoxicity test of four plasticizers by embryonic stem cell test (EST). AATEX. 2009;14:947-953.
54. UK, DHSS"Guidance Note on Applications for Product Licences". 1984:A14-1.
55. EC:"Guidelines on the quality, Safety and Efficacy of Medical Products for Human Use", III/3305/89-EN, 1989:99.
56. Supervision by the Planning Section of Environmental Health Bureau, Ministry of Health and Welfare. OECD Guidance Document on Toxicity Testing. Jiho, Inc. 1991, pp.1-226.
57. Braun AG, Emerson DJ, Nichinson BB.Teratogenic drugs inhibit tumour cell attachment to lectin-coated surfaces. Nature. 1979;282:507-509. (Pubitemid 10126543)
58. Yoneda T, Pratt RM. Mesenchymal cells from the human embryonic palate are highly re-sponsive to epidermal growth factor. Science. 1981;213:563-565. (Pubitemid 11045323)
59. Pratt RM, Willis WD. In vitro screening assay for teratogens using growth inhibition of hu-man embryonic cells.Proceedings of the National Academy of Sciences of the United States of America. 1985;82(17):5791-5794. (Pubitemid 16218849)
60. Trosko JE, Chang CC, Netzloff M. The role of inhibited cell-cell communication in terato-genesis.Teratogenesis, Carcinogenesis, & Mutagenesis. 1982;2(1):31-45. (Pubitemid 12130409)
61. Flint OP. A micromass culture method for rat embryonic neural cells. Journal of Cell Science. 1983;61:247-262. (Pubitemid 13064312)
62. Steele CE.Whole embryo culture and teratogenesis. Hum Reprod. 1991;6:144-147.
63. Schmid BP, Honegger P, Kucera P. Embryonic and fetal development: fundamental research. Reprod Toxicol. 1993;7 Suppl 1:155-164.
64. Spielmann H, Liebsch M. Lessons learned from validation of in vitro toxicity test: from failure to acceptance into regulatory practice. Toxicol In Vitro. 2001;15(4-5):585-590. (Pubitemid 32889689)
65. Piersma AH. Validation of alternative methods for developmental toxicity testing. Toxicol Lett. 2004;149(1-3):147-153. (Pubitemid 38469832)
66. Flick B, Klug S. Whole embryo culture: an important tool in developmental toxicology today. Curr Pharm Des. 2006;12:1467-1488. (Pubitemid 44082106)
67. Shepard TH, Fantel AG, Mirkes PE, Greenaway JC, Faustman-Watts E, Campbell M, Juchau MR. Teratology testing: I. Development and status of short-term prescreens. II. Biotransformation of teratogens as studied in whole embryo culture. Prog Clin Biol Res. 1983;135:147-64.
68. Sadler TW, Warner CW. Use of whole embryo culture for evaluating toxicity and teratogenicity. Pharmacol Rev. 1984;36(2 Suppl):145S-150S. (Pubitemid 14093526)
69. New DA. Whole embryo culture, teratogenesis, and the estimation of teratologic risk. Teratology. 1990;42:635-642.
70. Spielmann H. Predicting the risk of developmental toxicity from in vitro assays. Toxicol Appl Pharmacol. 2005;207(2 Suppl):375-380.
71. Evans MJ, Kaufmann MH. Establishment in culture of pluripotential cells from mouse em-bryos. Nature 1981;292:154-156. (Pubitemid 11050741)
72. Anderson D. In vitro models. Drug Saf. 1990;5 Suppl 1:27-39.
73. Uchino T, Takezawa T, Ikarashi Y, Tokunaga H. Construction of three-dimensional human skin model involving dendritic cells and its application to skin sensitization test. Yakugaku Zasshi. 2008;128:45-50.
74. Spielmann H, Hoffmann S, Liebsch M, Botham P, Fentem JH, Eskes C, Roguet R, Cotovio J, Cole T, Worth A, Heylings J, Jones P, Robles C, Kandárová H, Gamer A, Remmele M, Curren R, Raabe H, Cockshott A, Gerner I, Zuang V. The ECVAM international validation study on in vitro tests for acute skin irritation: report on the validity of the EPISKIN and EpiDerm assays and on the Skin Integrity Function Test. Altern Lab Anim. 2007;35:559-601. (Pubitemid 351169735)
75. Yan X, Owens DM. The skin: a home to multiple classes of epithelial progenitor cells. Stem Cell Rev. 2008;4:113-118.